Elevance Health Inc. (0HG8.L)
USD 371.42
(0.32%)
USD 371.42
(0.32%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 25.12 Billion USD | 4.17% |
| 2022 | 24.11 Billion USD | 4.7% |
| 2021 | 23.03 Billion USD | 14.95% |
| 2020 | 20.03 Billion USD | -0.25% |
| 2019 | 20.08 Billion USD | 4.55% |
| 2018 | 19.21 Billion USD | -3.62% |
| 2017 | 19.93 Billion USD | 26.74% |
| 2016 | 15.72 Billion USD | -0.87% |
| 2015 | 15.86 Billion USD | 4.7% |
| 2014 | 15.15 Billion USD | 4.56% |
| 2013 | 14.49 Billion USD | -3.25% |
| 2012 | 14.97 Billion USD | 52.91% |
| 2011 | 9.79 Billion USD | 9.4% |
| 2010 | 8.95 Billion USD | 6.6% |
| 2009 | 8.39 Billion USD | -5.0% |
| 2008 | 8.84 Billion USD | -2.24% |
| 2007 | 9.04 Billion USD | 28.94% |
| 2006 | 7.01 Billion USD | 3.06% |
| 2005 | 6.8 Billion USD | 59.14% |
| 2004 | 4.27 Billion USD | 107.15% |
| 2003 | 2.06 Billion USD | 2.34% |
| 2002 | 2.01 Billion USD | 78.73% |
| 2001 | 1.12 Billion USD | 88.9% |
| 2000 | 597.5 Million USD | 14.46% |
| 1999 | 522 Million USD | 72.9% |
| 1998 | 301.9 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 27.14 Billion USD | -1.94% |
| 2024 Q1 | 26.45 Billion USD | 5.3% |
| 2024 Q2 | 27.68 Billion USD | 4.67% |
| 2023 FY | 25.12 Billion USD | 4.17% |
| 2023 Q3 | 24.84 Billion USD | -1.11% |
| 2023 Q4 | 25.12 Billion USD | 1.11% |
| 2023 Q1 | 25.46 Billion USD | 5.61% |
| 2023 Q2 | 25.12 Billion USD | -1.34% |
| 2022 Q2 | 23.58 Billion USD | 1.43% |
| 2022 Q4 | 24.11 Billion USD | 1.44% |
| 2022 FY | 24.11 Billion USD | 4.7% |
| 2022 Q1 | 23.25 Billion USD | 0.97% |
| 2022 Q3 | 23.77 Billion USD | 0.78% |
| 2021 Q2 | 23.24 Billion USD | 0.03% |
| 2021 FY | 23.03 Billion USD | 14.95% |
| 2021 Q3 | 22.78 Billion USD | -1.96% |
| 2021 Q4 | 23.03 Billion USD | 1.08% |
| 2021 Q1 | 23.23 Billion USD | 15.97% |
| 2020 Q1 | 21.68 Billion USD | 7.96% |
| 2020 FY | 20.03 Billion USD | -0.25% |
| 2020 Q4 | 20.03 Billion USD | -3.88% |
| 2020 Q3 | 20.84 Billion USD | -2.95% |
| 2020 Q2 | 21.47 Billion USD | -0.95% |
| 2019 FY | 20.08 Billion USD | 4.55% |
| 2019 Q3 | 20.23 Billion USD | 4.84% |
| 2019 Q4 | 20.08 Billion USD | -0.72% |
| 2019 Q1 | 19.34 Billion USD | 0.68% |
| 2019 Q2 | 19.29 Billion USD | -0.24% |
| 2018 Q3 | 19.41 Billion USD | 0.69% |
| 2018 FY | 19.21 Billion USD | -3.62% |
| 2018 Q2 | 19.28 Billion USD | -3.02% |
| 2018 Q4 | 19.21 Billion USD | -1.07% |
| 2018 Q1 | 19.88 Billion USD | -0.23% |
| 2017 Q2 | 16.29 Billion USD | -4.96% |
| 2017 FY | 19.93 Billion USD | 26.74% |
| 2017 Q4 | 19.93 Billion USD | 22.8% |
| 2017 Q3 | 16.23 Billion USD | -0.38% |
| 2017 Q1 | 17.14 Billion USD | 9.0% |
| 2016 Q3 | 15.61 Billion USD | 0.26% |
| 2016 FY | 15.72 Billion USD | -0.87% |
| 2016 Q2 | 15.57 Billion USD | -1.48% |
| 2016 Q1 | 15.8 Billion USD | -0.38% |
| 2016 Q4 | 15.72 Billion USD | 0.75% |
| 2015 Q1 | 15.83 Billion USD | 4.54% |
| 2015 Q2 | 16.63 Billion USD | 5.01% |
| 2015 Q3 | 16.25 Billion USD | -2.25% |
| 2015 Q4 | 15.86 Billion USD | -2.43% |
| 2015 FY | 15.86 Billion USD | 4.7% |
| 2014 Q4 | 15.15 Billion USD | -0.73% |
| 2014 Q3 | 15.26 Billion USD | 3.15% |
| 2014 Q1 | 15.04 Billion USD | 3.79% |
| 2014 Q2 | 14.79 Billion USD | -1.62% |
| 2014 FY | 15.15 Billion USD | 4.56% |
| 2013 Q4 | 14.49 Billion USD | -2.51% |
| 2013 FY | 14.49 Billion USD | -3.25% |
| 2013 Q2 | 14.84 Billion USD | 0.42% |
| 2013 Q1 | 14.77 Billion USD | -1.33% |
| 2013 Q3 | 14.86 Billion USD | 0.15% |
| 2012 Q3 | 13.58 Billion USD | 21.87% |
| 2012 Q1 | 9.47 Billion USD | -3.29% |
| 2012 Q4 | 14.97 Billion USD | 10.23% |
| 2012 FY | 14.97 Billion USD | 52.91% |
| 2012 Q2 | 11.14 Billion USD | 17.69% |
| 2011 FY | 9.79 Billion USD | 9.4% |
| 2011 Q4 | 9.79 Billion USD | -2.01% |
| 2011 Q1 | 9 Billion USD | 0.53% |
| 2011 Q2 | 8.84 Billion USD | -1.7% |
| 2011 Q3 | 9.99 Billion USD | 12.97% |
| 2010 Q1 | 8.39 Billion USD | -0.1% |
| 2010 FY | 8.95 Billion USD | 6.6% |
| 2010 Q2 | 8.54 Billion USD | 1.89% |
| 2010 Q4 | 8.95 Billion USD | -0.78% |
| 2010 Q3 | 9.02 Billion USD | 5.56% |
| 2009 Q2 | 9.17 Billion USD | -1.78% |
| 2009 Q3 | 8.86 Billion USD | -3.38% |
| 2009 Q4 | 8.39 Billion USD | -5.23% |
| 2009 FY | 8.39 Billion USD | -5.0% |
| 2009 Q1 | 9.33 Billion USD | 5.61% |
| 2008 Q4 | 8.84 Billion USD | -4.05% |
| 2008 Q1 | 9.28 Billion USD | 2.68% |
| 2008 Q2 | 9.76 Billion USD | 5.2% |
| 2008 FY | 8.84 Billion USD | -2.24% |
| 2008 Q3 | 9.21 Billion USD | -5.67% |
| 2007 Q3 | 8.7 Billion USD | 6.49% |
| 2007 Q4 | 9.04 Billion USD | 3.92% |
| 2007 FY | 9.04 Billion USD | 28.94% |
| 2007 Q2 | 8.17 Billion USD | 15.0% |
| 2007 Q1 | 7.1 Billion USD | 1.32% |
| 2006 Q3 | 7.34 Billion USD | -1.67% |
| 2006 FY | 7.01 Billion USD | 3.06% |
| 2006 Q4 | 7.01 Billion USD | -4.49% |
| 2006 Q2 | 7.46 Billion USD | 4.61% |
| 2006 Q1 | 7.14 Billion USD | 4.91% |
| 2005 Q1 | 4.27 Billion USD | -0.08% |
| 2005 Q2 | 4.62 Billion USD | 8.17% |
| 2005 Q3 | 4.37 Billion USD | -5.3% |
| 2005 FY | 6.8 Billion USD | 59.14% |
| 2005 Q4 | 6.8 Billion USD | 55.47% |
| 2004 Q4 | 4.27 Billion USD | 125.21% |
| 2004 Q3 | 1.89 Billion USD | -9.28% |
| 2004 Q2 | 2.09 Billion USD | 1.01% |
| 2004 FY | 4.27 Billion USD | 107.15% |
| 2004 Q1 | 2.07 Billion USD | 0.38% |
| 2003 Q2 | 2.03 Billion USD | -0.33% |
| 2003 Q3 | 2.1 Billion USD | 3.52% |
| 2003 Q4 | 2.06 Billion USD | -2.12% |
| 2003 FY | 2.06 Billion USD | 2.34% |
| 2003 Q1 | 2.04 Billion USD | 1.33% |
| 2002 Q3 | 2.02 Billion USD | 80.58% |
| 2002 FY | 2.01 Billion USD | 78.73% |
| 2002 Q4 | 2.01 Billion USD | -0.61% |
| 2002 Q1 | 1.17 Billion USD | 4.45% |
| 2002 Q2 | 1.12 Billion USD | -4.66% |
| 2001 FY | 1.12 Billion USD | 88.9% |
| 2001 Q4 | 1.12 Billion USD | 30.21% |
| 2001 Q3 | 866.8 Million USD | 0.0% |
| 2000 FY | 597.5 Million USD | 14.46% |
| 1999 FY | 522 Million USD | 72.9% |
| 1998 FY | 301.9 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Phreesia, Inc. | 11.98 Million USD | -209530.31% |
| Accuray Incorporated | 172.15 Million USD | -14491.417% |
| Align Technology, Inc. | 96.96 Million USD | -25805.453% |
| AxoGen, Inc. | 69.29 Million USD | -36152.381% |
| Boston Scientific Corporation | 9.09 Billion USD | -176.135% |
| CVS Health Corporation | 79.38 Billion USD | 68.357% |
| Cardinal Health, Inc. | 5.6 Billion USD | -347.852% |
| Centene Corporation | 17.69 Billion USD | -41.929% |
| DaVita Inc. | 11.11 Billion USD | -125.972% |
| HCA Healthcare, Inc. | 41.85 Billion USD | 39.989% |
| Hologic, Inc. | 2.53 Billion USD | -891.083% |
| Humana Inc. | 10.21 Billion USD | -145.961% |
| IDEXX Laboratories, Inc. | 947.88 Million USD | -2550.124% |
| Laboratory Corporation of America Holdings | 5.95 Billion USD | -321.887% |
| Masimo Corporation | 970 Million USD | -2489.691% |
| McKesson Corporation | 5.47 Billion USD | -359.064% |
| Patterson Companies, Inc. | 762.94 Million USD | -3192.526% |
| Quest Diagnostics Incorporated | 5.36 Billion USD | -367.871% |
| ResMed Inc. | 873.93 Million USD | -2774.356% |
| Henry Schein, Inc. | 2.74 Billion USD | -816.454% |
| Teladoc Health, Inc. | 1.59 Billion USD | -1477.615% |
| Universal Health Services, Inc. | 5.36 Billion USD | -368.078% |
| Veeva Systems Inc. | 55.77 Million USD | -44938.1% |
| Baxter International Inc. | 14.36 Billion USD | -74.882% |
| Becton, Dickinson and Company | 15.87 Billion USD | -58.196% |
| Intuitive Surgical, Inc. | 89.8 Million USD | -27873.274% |
| Danaher Corporation | 19.35 Billion USD | -29.779% |
| Stryker Corporation | 12.99 Billion USD | -93.305% |
| Medtronic plc | 24.96 Billion USD | -0.629% |